Erden, Abdulsamet
Ayan, Gizem
Kilic, Levent
Solmaz, Dilek
Bakirci, Sibel
Kimyon, Gezmis
Günal, Esen Kasapoglu
Dogru, Atalay
Bayindir, Ozun
Dalkilic, Ediz
Özisler, Cem
Akar, Servet
Cetin, Gözde Yildirim
Tarhan, Emine Figen
Küçüksahin, Orhan
Omma, Ahmet
Gonullu, Emel
Yildiz, Fatih
Ersozlu, Emine Duygu
Cinar, Muhammed
Tufan, Abdurrahman
Pehlevan, Seval
Esmen, Serpil Ergulu
Yilmaz, Sema
Duruoz, Tuncay
Kasifoglu, Timucin
Yazısız, Veli
Aksu, Kenan
Aydin, Sibel Zehra
Kalyoncu, Umut https://orcid.org/0000-0001-7129-2109
Article History
Received: 7 November 2022
Revised: 19 December 2022
Accepted: 21 December 2022
First Online: 13 January 2023
Compliance with ethical standards
:
: This study was conducted in accordance with the Declaration of Helsinki and approved by the local ethics board [Hacettepe University Ethics Board, Ankara (GO 14/578)] and informed consent was obtained from all patients before data collection.
: Sibel Zehra Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, Pfizer, Eli Lilly and Sanofi, research grants from Abbvie, Jannsen, Novartis, Eli Lilly, UCB, Pfizer, Sanofi. Emine Duygu Ersozlu received honoraria from Abbvie, Pfizer, Amgen, MSD and Veli Yazisiz received honoraria from Abbvie, Pfizer, UCB, Novartis, MSD. The other authors declared no competing interests.
Free to read: This content has been made available to all.